New brain decoder offers hope for improving communication in aphasia

People with aphasia-a brain disorder affecting about a million people in the U.S.-struggle to turn their thoughts into words and comprehend spoken language.

ASU professor offers insights on what may be coming from Neuralink’s PRIME study

This week, Neuralink’s Elon Musk announced that human clinical trials have begun on its Precise Robotically Implanted Brain-Computer Interface (PRIME) study, a medical device trail

February 3, 2024

European companies outline opposition to proposed overhaul of pharma policy

BRUSSELS — Leaders of European pharmaceutical companies on Wednesday said that a proposed overhaul of the E.U.’s medicines policies could render the region’s industry less competitive,

June 21, 2023

With Menendez indictment, pharmaceutical industry could lose a key ally

WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic

September 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.